Fran Newark serves as the Director of Clinical Operations at Perspective Therapeutics, where she leverages her extensive experience in both Contract Research Organizations (CROs) and biotech sponsorship to drive the successful execution of clinical trials across all phases, from I to IV. With a proven...
Fran Newark serves as the Director of Clinical Operations at Perspective Therapeutics, where she leverages her extensive experience in both Contract Research Organizations (CROs) and biotech sponsorship to drive the successful execution of clinical trials across all phases, from I to IV. With a proven track record in global clinical research, Fran is adept at overseeing the operational delivery of clinical trials for various oncology programs, ensuring that each study adheres to the highest standards of compliance and efficiency.
Her leadership has been instrumental in managing key projects that focus on innovative treatment modalities, particularly in the oncology space. Fran's expertise in clinical trial management systems (CTMS) allows her to streamline processes, enhance data analysis, and improve business operations, ultimately leading to better patient outcomes. She is also skilled in vendor management, which is crucial for coordinating with external partners and ensuring that all aspects of the clinical trials are executed seamlessly.
Recognized as the PharmaTimes Clinical Researcher of the Year 2020, where she was awarded 2nd place in the Clinical Trial Manager category, Fran's commitment to excellence is evident in her approach to team training and development. She fosters a collaborative environment that encourages knowledge sharing and continuous improvement among her team members. By focusing on patient-reported outcomes and integrating feedback into trial designs, Fran ensures that the voice of the patient remains central to the research process. Her multifaceted skill set and dedication to advancing clinical operations make her a key asset to Perspective Therapeutics and the broader field of oncology research.
